Top Markets
Coin of the day
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
주식 순위 #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
주가
$0.53499835
시가총액
$40.24M
변동 (1일)
2.50%
변동 (1년)
-58.07%
국가
JP
거래 Chordia Therapeutics Inc. (190A)

카테고리

Chordia Therapeutics Inc. (190A)의 주가 이력
최고 종가: $0.53 (2026-08-01 기준)

최저 종가: $1.06 (2024-06-01 기준)
Chordia Therapeutics Inc.의 주가 이력 (2024 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) 10.93%
2025 -61.05%
2024 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$544.13 37.98%
US
$1.04K 56.62%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$131.42 388.73%
US